HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
3.690
-0.150 (-3.91%)
Nov 7, 2024, 4:00 PM EST - Market closed

HOOKIPA Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-48.6-81.58-64.92-75.67-44.08-43.04
Upgrade
Depreciation & Amortization
3.123.553.64.644.153.07
Upgrade
Asset Writedown & Restructuring Costs
12.7712.77----
Upgrade
Stock-Based Compensation
1.22.355.047.648.665.57
Upgrade
Other Operating Activities
0.060.060.161.230.050.05
Upgrade
Change in Accounts Receivable
0.676.18-0.34-1.94-3.58-3.62
Upgrade
Change in Accounts Payable
0.066.5-20.866.34.2
Upgrade
Change in Unearned Revenue
-39.93-8.2635.511.420.51-4.44
Upgrade
Change in Other Net Operating Assets
-3.230.912.95-4.2-11.35-3.52
Upgrade
Operating Cash Flow
-73.88-57.52-20-66.02-39.34-41.73
Upgrade
Capital Expenditures
-3.6-4.16-5.02-12.58-2.37-2
Upgrade
Investing Cash Flow
-3.6-4.16-5.02-12.58-2.37-2
Upgrade
Long-Term Debt Repaid
--1.75-2.85-0.44-1.42-2.28
Upgrade
Net Debt Issued (Repaid)
-1.14-1.75-2.85-0.44-1.42-2.28
Upgrade
Issuance of Common Stock
20.8549.0445.690.242.6474.76
Upgrade
Other Financing Activities
-0.14-0.15-0.2--0.22-
Upgrade
Financing Cash Flow
19.3165.6772.27-0.2473.42109.75
Upgrade
Foreign Exchange Rate Adjustments
-0.490.09-0.732.57-2.11-1.03
Upgrade
Net Cash Flow
-58.664.0846.53-76.2729.665
Upgrade
Free Cash Flow
-77.48-61.68-25.01-78.6-41.71-43.73
Upgrade
Free Cash Flow Margin
-148.53%-306.44%-175.55%-426.05%-212.98%-366.19%
Upgrade
Free Cash Flow Per Share
-6.54-6.53-3.82-23.94-16.02-24.48
Upgrade
Cash Interest Paid
0.010.010.030.050.10.06
Upgrade
Cash Income Tax Paid
0.20.400--
Upgrade
Levered Free Cash Flow
-46.05-39.97-31.83-55.19-29.82-30.12
Upgrade
Unlevered Free Cash Flow
-45.98-39.77-31.4-54.63-29.33-29.57
Upgrade
Change in Net Working Capital
14.94-11.57-10.73.286.464.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.